News

SEARCH FIRM NEWS

news September 16, 2019

FTC eyes more aggressive action against CBD disease claims

While targeting claims that CBD treats serious diseases like cancer, the Federal Trade Commission has issued a few rounds of warning letters—including three this month. But in an interview with Natural Products INSIDER, an FTC official suggested the agency will take more forceful enforcement action in the future against marketers who advertise CBD as a […]

news June 6, 2019

Amin Talati Law Firm Announces Name Change; Plans to Continue Expansion in Core Areas

Leading regulatory and intellectual property law firm Amin Talati today announced that effective June 1, 2019, the firm’s name changed to Amin Talati Wasserman LLP, making Ivan Wasserman, who also serves as the firm’s managing partner, a name partner. “Our new name is a reflection of how far we have come and how far we […]

news February 6, 2019

Prominent Medical Device Attorney, Neil O’Flaherty, Joins Amin Talati in Washington, DC

Neil O’Flaherty has over 28 years of experience involving FDA regulation of medical devices and other products. He has spoken, written and advised extensively on medical device and other FDA-related topics, including the regulation of mobile medical apps and other medical software products, in vitro diagnostics (including genetic and other laboratory tests), human cells, tissues, and […]

news January 17, 2019

Katie Bond Shares Her Thoughts on How to Back Up Advertising Claims and Avoid Risk

New Hope Network recently featured an article published by Katie Bond titled, “How to Back Up Advertising Claims and Avoid Risk”. Katie discusses the recent regulatory landscape with respect to advertising law and provides valuable insight into strategies for mitigating risk. To read the full article, please click HERE.

news January 2, 2019

ATU Arguments Prevail Again in One of the “Biggest Patent Cases of 2018”

Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of the five Biggest Patent Cases of 2018.  Amin Talati Upadhye LLP attorneys submitted Comments of Amici Curiae to the PTAB […]

news December 7, 2018

Amin Talati Bolsters Trademark Practice With Addition of Two IP Leaders

Ms. Roach’s practice focuses exclusively on the trademark lifecycle. Since 2006, she has counseled clients on brand selection, portfolio strategy, trademark application prosecution, brand enforcement and defense, anti-counterfeiting measures, and trademark maintenance stretching from the United States to more than 140 countries around the world. Her extensive knowledge of trademark law helps her clients secure […]

publication September 11, 2018

Don’t let state legislation affecting food, dietary supplements fly under radar

"Don’t let state legislation affecting food, dietary supplements fly under radar". September 11, 2018. Published by Rend Al-Mondhiry in Natural Product Insider.

publication July 24, 2018

Update on the Amarin-ITC Case and the Issues at Stake

"Update on the Amarin-ITC Case and the Issues at Stake". July 24, 2018. Published by Rend Al-Mendhiry, JD and Jennifer M. Adams, JD in Regulatory Affairs Professionals Society.

What's Now

Rend Al-Mondhiry Elevated To Partner At Amin Talati

Amin Talati Wasserman LLP announced today that Rend Al-Mondhiry has been elevated to Partner of the firm. Rend is one of the most well-known and respected attorneys serving the dietary supplement industry.  Since joining the MORE >

see all news >